Intravenous Ketamine “Burst” for Refractory Depression in a Patient with Advanced Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Intravenous Ketamine “Burst” for Refractory Depression in a Patient with Advanced Cancer

Published:2008-11 Issue:9 Volume:11 Page:1268-1271
ISSN:1096-6218
Container-title:Journal of Palliative Medicine
language:en
Short-container-title:Journal of Palliative Medicine

Author:

Stefanczyk-Sapieha Lilianna¹,Oneschuk Doreen²,Demas Michael³

Affiliation:

1. Palliative Medicine, University Health Network, Toronto General Hospital Toronto, Ontario, Canada.

2. Division of Palliative Care Medicine, Department of Oncology, University of Alberta, Edmonton, Alberta, Canada.

3. Department of Psychiatry, Grey Nuns Hospital, Edmonton, Alberta, Canada.

Publisher

Mary Ann Liebert Inc

Subject

Anesthesiology and Pain Medicine,General Medicine,General Nursing

Link

http://www.liebertpub.com/doi/pdf/10.1089/jpm.2008.9828

Reference22 articles.

1. Affective disorders in advanced cancer

2. Psychological Issues in End-of-Life Care

3. Antidepressant effects of ketamine in depressed patients

4. A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression

5. Small-Dose Ketamine Improves the Postoperative State of Depressed Patients

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fármacos enteógenos y la depresión resistente al tratamiento: Una revisión narrativa;Psicumex;2024-06-01

2. Ketamine subcutaneous continuous infusion for depressive symptoms at home: A case report beyond pain use;Palliative and Supportive Care;2024-05-06

3. Successful treatment for serious depression with suicidal risk in a heart transplant patient;Revista Colombiana de Psiquiatría (English ed.);2024-04

4. A Phase II, Open-Label Clinical Trial of Intranasal Ketamine for Depression in Patients with Cancer Receiving Palliative Care (INKeD-PC Study);Cancers;2023-01-07

5. Use of ketamine for depression and suicidality in cancer and terminal patients: Review of current data;AIMS Public Health;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3